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Abstract:  24 
 Photovoltaic arrays (PVA) implanted into the subretinal space of patients with retinitis 25 
pigmentosa (RP) are designed to electrically stimulate the remaining inner retinal circuitry in 26 
response to incident light, thereby recreating a visual signal when photoreceptor function 27 
declines or is lost. Preservation of inner retinal circuitry is critical to the fidelity of this transmitted 28 
signal to ganglion cells and beyond to higher visual targets. Post-implantation loss of retinal 29 
interneurons or excessive glial scarring could diminish and/or eliminate PVA-evoked signal 30 
transmission. As such, assessing the morphology of the inner retina in RP animal models with 31 
subretinal PVAs is an important step in defining biocompatibility and predicting success of signal 32 
transmission. In this study, we used immunohistochemical methods to qualitatively and 33 
quantitatively compare inner retinal morphology after the implantation of a PVA in two RP 34 
models: the Royal College of Surgeons (RCS) or transgenic S334ter-line 3 (S334ter-3) 35 
rhodopsin mutant rat. Two PVA designs were compared. In the RCS rat, we implanted devices 36 
in the subretinal space at 4 weeks of age and histologically examined them at 8 weeks of age 37 
and found inner retinal morphology preservation with both PVA devices. In the S334ter-3 rat, we 38 
implanted devices at 6 to 12 weeks of age and again, inner retinal morphology was generally 39 
preserved with either PVA design 16 to 26 weeks post implantation. Specifically, the length of 40 
rod bipolar cells and numbers of cholinergic amacrine cells were maintained along with their 41 
characteristic inner plexiform lamination patterns. Throughout the implanted retinas we found 42 
nonspecific glial reaction, but none showed additional glial scarring at the implant site. Our 43 
results indicate that subretinally implanted PVAs are well-tolerated in rodent RP models and that 44 
the inner retinal circuitry is preserved, consistent with our published results showing implant-45 
evoked signal transmission.  46 
Keywords: retina, prosthetic, bipolar cells, amacrine cells, Mller glial cells  47 
3 
1. Introduction 48 
 Retinitis pigmentosa (RP) and age-related macular degeneration (AMD) are leading 49 
causes of irreversible blindness worldwide (Hartong et al., 2006). In these diseases, vision loss, 50 
regardless of underlying etiology, results from degeneration of retinal photoreceptors. 51 
Remodeling of the inner retina occurs in late stages of disease (Jones and Marc, 2005; Marc 52 
and Jones, 2003; Marc et al., 2007; Strettoi et al., 2002), but photoreceptor degeneration leaves 53 
the neurons and circuitry of the inner retina relatively intact for extended periods of time 54 
(Humayun et al., 1999; Jones et al., 2003; Marc and Jones, 2003; Marc et al., 2007; Strettoi et 55 
al., 2002; Strettoi et al., 2003).   56 
One promising approach that targets the remaining retinal circuitry to restore lost vision 57 
uses prosthetic devices to functionally replace photoreceptors. Several different designs and 58 
placement strategies are currently being evaluated. Epiretinal placement and stimulation of the 59 
retinal ganglion cells (RGC) should require algorithms to selectively achieve information 60 
transmission (Jensen et al., 2005; Humayun et al., 2012). Suprachoroidal implants (Cicione et 61 
al., 2012; Kanda et al., 2004; Morimoto et al., 2011; Wong et al., 2009; Yamauchi et al., 2005) 62 
and subretinal microphotodiode arrays (Chow et al., 2001; Mathieson et al., 2012; Rizzo, 2011; 63 
Zrenner et al., 1999) are designed to directly stimulate bipolar cells and theoretically utilize 64 
network-mediated retinal stimulation, preserving the integrative properties of second order 65 
neurons in the inner plexiform layer (IPL) (Asher et al., 2007; Wang et al., 2012). Other 66 
strategies utilize optogenetics to confer light sensitivity to bipolar or RGCs (Bi et al., 2006; 67 
Busskamp et al., 2012; Garg and Federman, 2013; Isago et al., 2012; Lin et al., 2008; Tomita et 68 
al., 2007) to directly stimulate retinal tissues.  69 
Subretinally placed photovoltaic arrays (PVAs) provide targeted stimulation to the inner 70 
nuclear layer (INL) (Fransen et al., 2014) due to their current density distribution and size 71 
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(Mathieson et al. 2012). Because bipolar cells are interneurons that connect photoreceptors to 72 
RGCs they are involved in signal transmission with PVAs. Retention of these cells and 73 
formation of a functional retinal-prosthetic interface would aid in visual restoration. For this to 74 
occur there must be a high level of biocompatibility between the retina and prosthesis. As such, 75 
measures of the integrity of the bipolar cells and other retinal constituents are critical 76 
components to the evaluation of the success of any subretinal prosthetic.  77 
 Previous studies have attempted to characterize the condition of implanted and/or 78 
electrically stimulated retinal tissue histologically and immunohistochemically (Alamusi et al., 79 
2013; Chow et al., 2001; Pardue et al., 2001; Ray et al., 2009; Ray et al., 2011; Tamaki et al., 80 
2008). However, many of these studies have examined the effects only of certain aspects of the 81 
treatment paradigm, such as acute electrical stimulation or biocompatibility of a prosthetic 82 
device in wild-type animals that do not exhibit degenerative pathology. In this study, we 83 
examined retinal morphology after implantation of two generations of subretinal silicon devices 84 
in two RP rat models. We compared a monopolar PVA (mPVA) with no perforations (Chow et 85 
al., 2001) to a bipolar PVA (bPVA), which includes bipolar pixels separated by 5 ȝP gaps 86 
(Mathieson et al., 2012). Photovoltaic pixels in monopolar devices have individual active 87 
electrodes, but share a common large return electrode on the back side of the implant. Bipolar 88 
pixels are composed of 3 photodiodes in series, connected between the active electrode in the 89 
center of the pixel and a return electrode surrounding each pixel (Mathieson et al., 2012). All 90 
devices in the present study were photoactive. The bPVA gaps enhance proximity of the 91 
electrodes to inner retinal neurons and allow diffusion of extracellular milieu through the implant 92 
(Adkins et al., 2013; Mathieson et al., 2012). Since the subretinal PVA stimulates retinal 93 
neurons that are within close proximity to the electrode (Fransen et al., 2014), we focused our 94 
analysis on inner retinal cells that are likely activated by the PVA device. Rod bipolar cells and 95 
cholinergic amacrine cells represent well defined populations of cells with robust cellular 96 
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markers to assess overall inner retinal health. We also assessed glial reaction in tissues within 97 
and distal to the implant site from 16 to 26 weeks post implantation in the S334ter-3 and 4 98 
weeks post implantation in the RCS rat. Our results suggest that both the mPVA and bPVA 99 
designs are well tolerated and preserve the necessary inner retinal circuitry that underlie the 100 
transmission of signals to the RGCs and beyond (Fransen et al., 2014). 101 
2. Methods 102 
2.1 Animals and Experimental Groups 103 
 All animal procedures were approved by the Institutional Animal Care and Use 104 
Committee and conformed to the ARVO Statement for the Use of Animals in Ophthalmology 105 
and Vision Research. Two models of RP were used: the Royal College of Surgeons (RCS) and 106 
S334ter-3 rats from an in-house breeding colony originated from breeders donated by Dr. 107 
Matthew LaVail (University of California, San Francisco) (LaVail et al., 1975; Mullen and LaVail, 108 
1976).  109 
The RCS rats (n=4) were implanted binocularly at 4 weeks of age and terminated 4 110 
weeks post-implantation. RCS rats exhibit a moderate rate of photoreceptor degeneration; 111 
approximately 50% of the initial ONL thickness was present at the age of implantation (LaVail 112 
and Battelle, 1975). Four eyes were implanted with an mPVA device and 4 with a bPVA device. 113 
The eyes were divided such that all bPVA-implanted eyes were processed as frozen sections 114 
for retinal cross-sections and half the mPVA eyes processed similarly with the remaining 115 
prepared as retinal flat mounts. 116 
 S334ter-3 rats were implanted monocularly (right eye) with either an mPVA (n=4) or a 117 
bPVA (n=7) from 6 to 12 weeks of age and were terminated at 22 to 32 weeks of age (16-26 118 
weeks of implantation). Monocular implantation accommodated superior colliculus recordings 119 
that are reported elsewhere (Fransen et al., 2014). The S334ter-3 is a rapid degeneration model 120 
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and most photoreceptors had degenerated at the time of implantation (McGill et al., 2012). All 121 
S334ter-3 eyes were processed as frozen sections. Additional cross sections were analyzed 122 
from three age-matched unimplanted control eyes from each RP strain, as well as 3 eyes from 123 
8-week-old Long Evans wild-type rats acquired from Charles River.  124 
2.2 Overview of Devices 125 
Two types of PVA were explored: mPVA and bPVA (Mathieson et al., 2012; Pardue et 126 
al., 2005b). mPVA devices, provided by Optobionics, Inc (Glen Ellyn, IL), were fabricated using 127 
previously described thin-film fabrication methods (Chow et al., 2001). The mPVA is a 1 mm 128 
diameter silicon disk, 25 ȝPthick, containing 1200 microphotodiodes with active electrodes on 129 
one face and a common return electrode on the back, both coated with iridium oxide (Chow et 130 
al., 2001).  7KHE39$GHYLFH¶VSKRWRYROWDLFDUUD\VZHUHFRPSRVHGRIWULSOH-diode pixels 131 
fabricated on a silicon wafer.  Each pixel contains an active electrode in its center and a return 132 
electrode at the circumference. Upon illumination with a pulse of light, each pixel generates a bi-133 
phasic pulse of electric current flowing through the tissue between electrodes, primarily 134 
stimulating the inner nuclear layer (INL) cells (Fransen et al., 2014). Electrodes were coated in 135 
iridium oxide and the details of manufacturing methods of the bPVA were published previously 136 
(Wang et al., 2012). Five-ȝPwide gaps were etched between adjacent pixels for electrical 137 
isolation and to improve nutrients flow through the implant (Mathieson, et al. 2012). The bPVA 138 
device measured 0.8 x 1.2 mm and was 30-ȝPthick. bPVA devices were left in retinal tissue for 139 
histological analysis due to tissue destruction caused by removal. 140 
 141 
2.3 Surgical Procedure 142 
 The surgical methods employed for implantation of the PVAs into the subretinal space 143 
have been described previously (Pardue et al., 2005b). Briefly, rats were anesthetized 144 
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[ketamine (60 mg/kg) and xylazine (7.5 mg/kg)] and placed into a sterile field. A traction suture 145 
was made at the superior limbus and the eye was rotated inferiorly. A ~1.0 mm incision was 146 
made in the superior globe reaching the vitreous. The eye was hydrated with a drop of saline, 147 
and a 10 minute waiting period was observed which allowed the retina to detach from the RPE. 148 
The PVA was then slid into the subretinal space with the electrodes in contact with the retina. 149 
Successful subretinal placement was confirmed via fundus examination and subsequent 150 
spectral domain-ocular coherence tomography (SD-OCT) imaging (Heidelberg HRA+OCT, 151 
Carlsbad, CA) (Fransen et al., 2014).  Implants rested in the superior-temporal retina from 0.5 to 152 
1 mm from the optic nerve head.   153 
2.4 Immunohistochemistry 154 
2.4.1 Cross-sections 155 
Following anesthesia [ketamine (60 mg/kg)/xylazine (7.5 mg/kg)] and sacrifice [390 156 
mg/mL pentobarbital sodium (Euthasol, Virbac AH, Inc., Fort Worth, TX)], eyes were 157 
immediately enucleated and fixed in 4% paraformaldehyde for 30 minutes. The posterior eyecup 158 
was bisected in the superior/inferior plane near the optic nerve, ensuring that the entire implant 159 
was intact and present in only one of the two resulting halves (Figure 1A). mPVA devices were 160 
gently extracted from the subretinal space using hydrodissection. bPVAs, which contain gaps 161 
through which the retinal tissue migrates (Palanker et al., 2004), were left in place to preserve 162 
retinal morphology around the implant. The tissue was cryoprotected overnight in 30% sucrose 163 
in 0.1M PBS and frozen in embedding medium (O.C.T. Tissue-Tek¨, Sakura Finetek, Tokyo). 164 
Retinal sections in the superior/inferior plane (20-30 ȝP) were cut on a cryostat and thaw-165 
mounted on glass slides. Sections containing the implant site were mounted on the same slide 166 
with sections from the corresponding non-LPSODQWHGKDOIUHIHUUHGWRDV³GLVWDO´WLVVXHVRWKDW167 
both sections received equal reagent exposure. 168 
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Table 1 lists the antibodies used, along with working dilutions and sources. Rod bipolar 169 
cells were labeled with anti-SURWHLQNLQDVH&DOSKDVXEXQLW3.&Į.RVDNDHWDO0OOHU170 
glial reaction in response to ocular stress was assessed with antibodies to glial fibrillary acidic 171 
protein (GFAP) (Bringmann et al., 2006). Finally, cholinergic amacrine cells and IPL lamination 172 
patterns were visualized with anti-choline acetyltransferase (ChAT) antibodies (Dijk and 173 
Kamphuis, 2004). The incubation protocol has been described previously (Lee et al., 2008). 174 
Briefly, following a wash in 1.0 M PBS slides were blocked for 1 hour at room temperature (10% 175 
donkey serum, 1% BSA, and 1% Triton X-100 in 1.0 M PBS). Primary and secondary antibodies 176 
were diluted in 1.0 M PBS containing 0.5% Triton X-100. Sections were incubated with primary 177 
antibodies overnight at 4¡C and secondary antibodies for 2 hours at room temperature. 178 
Fluorescent secondary antibodies included donkey-anti-rabbit-DyLight¨ 488 (Abcam, 179 
Cambridge, MA) and donkey-anti-goat-DyLight¨ 594 (Abcam, Cambridge, MA), both diluted 180 
1:300. Sections were stained with DAPI, mounted with mounting medium (VectaShield¨ Hard 181 
Set, Vector Laboratories, Inc., Burlingame, CA), and coverslipped.  182 
 Sections were visualized and images taken on a confocal microscope (Eclipse Ti 183 
microscope with D-Eclipse C1 confocal controller, Nikon, Tokyo). Z-stack images spanning the 184 
section thickness at 1 ȝPintervals were captured using a 40 X oil immersion lens directly under 185 
WKHLPSODQWVLWH³LPSODQWHG´LPPHGLDWHO\DGMDFHQWWRWKHLPSODQWVLWH³DGMDFHQW´DQG³GLVWDO´186 
tissue from the non-implanted portion of the eye (see Figure 1A). Images of unimplanted control 187 
tissue were acquired from central, superior retinal sections. The Z-stack images were 188 
condensed into max-intensity volume projections and processed using commercial software 189 
,PDJH-1,+%HWKHVGD0'DQG3KRWRVKRS$GREH6\VWHPV,QF6DQ-Rse, CA). For 190 
comparisons of cross sections, extended-focus confocal images were composed of a stack of 191 
26 images along the z-axis. ChAT flat mounted extended-focus confocal images were 192 
comprised of a stack of 5 planes, each 1 ȝPthick. Pinhole size, gain, photo multiplier, and 193 
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offset of the confocal microscope were standardized within experimental groups. Brightness and 194 
contrast optimization was applied equally across all images, except images of GFAP-labeled 195 
sections in which no optimization was performed. 196 
2.4.2 Quantification  197 
Digital confocal cross-sections were analyzed using an image program (Image J, 198 
National Institute of Health, Bethesda, MA). Cross-sections of immuno-labeled S334ter-3 199 
retinas, implanted with either mPVA or bPVA were quantified in the following ways: 1) the length 200 
RI3.&ĮODEHOHGURGELSRODUFHOOVZHUHmeasured from the center of the soma to the axon 201 
terminals, 2) intensity of GFAP immunofluorescence was measured, and 3) the number of INL-202 
placed and displaced (in RGC layer) ChAT-positive amacrine nuclei were counted. For each 203 
quantification, at least 2 sections from 2-4 retinas were analyzed. Triplicate measurements of 204 
rod bipolar cells from summed z-VWDFN3.&Į-labeled images were made on each section and 205 
averaged.  GFAP immunoreactivity was quantified by measuring the intensity of a 55 x 40 ȝP206 
region of interest (ROI) beginning at the retinal ganglion cell layer extending into the inner 207 
plexiform layer and normalized to a background region without tissue of similaUVL]H3.&ĮDQG208 
GFAP data was normalized to the distal regions to compare implant designs between different 209 
ages.  ChAT-labeled z-stacks were summed and the number of ChAT positive nuclei was 210 
measured along a 150-ȝPlength on each section.  211 
Statistical comparisons between mPVA and bPVA devices from each retinal region were 212 
made with two-way repeated measures ANOVA using Holm-Sidak post-hoc comparisons 213 
(Sigmastat v3.5 ,Systat Software, San Jose, CA).   214 
2.4.3 Flat mounts 215 
A subset of RCS eyes was processed as flat mounts, as described previously (Bernstein 216 
and Guo, 2011), with the following modifications. Eyes were enucleated and fixed in 4% 217 
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paraformaldehyde for 2 hours. The posterior eye cups were digested in hyaluronidase (1mg/mL; 218 
Sigma-Aldrich, St. Louis, MO) diluted 1:500 in 1.0 M PBS for 30 minutes. The retinas were 219 
carefully dissected from the retinal pigment epithelium (RPE), washed twice in PBST (0.5% 220 
Triton X-100 in 1.0M PBS), and then frozen in PBST at -80¡C for 15 minutes. After thawing 221 
slowly at room temperature, the retina was washed twice in PBST, blocked (10% donkey serum, 222 
0.25% Triton X-100 in 1.0M PBS) for 4 hours at room temperature, and incubated in anti-ChAT 223 
antibody (Table 1) overnight at 4¡C. After 3 washes in PBST, donkey-anti-goat-DyLight¨ 594 224 
secondary antibody (1:300; Abcam, Cambridge, MA) was applied for 1 hour at room 225 
temperature. Following additional washes, retinas were stained with DAPI, cut into a cloverleaf 226 
shape, and flattened on glass slides with the RGC layer face up. The retinas were mounted with 227 
mounting medium (VectaShield¨ Hard Set, Vector Laboratories, Inc., Burlingame, CA) and 228 
coverslipped. 229 
 The flat mounts were imaged using the confocal system, as described above, to 230 
generate Z-stack images over the implant site and distal regions of the same retina. 3D 231 
recreations were assembled and rotated using the 3D Viewer Plugin (ImageJ, NIH, Bethesda, 232 
0'&RQWUDVWDQGEULJKWQHVVZHUHRSWLPL]HGHTXDOO\DFURVVLPDJHV3KRWRVKRS$GREH233 
Systems, Inc., San Jose, CA). 234 
3. Results 235 
3.1 Rod bipolar cells maintained in both implant designs and RP models  236 
 5RGELSRODUFHOOVZHUHODEHOHGIRU3.&ĮLQERWK5&6DQG6WHU-3 rat eyes implanted 237 
with either PVA design. Figure 1A shows a fundus image of an mPVA in an RCS rat and the 238 
superimposed colored lines indicate the areas of the retina sampled in each of the subsequent 239 
figures. Blue indicates the area within the implant site, red the area adjacent to and green the 240 
area distal to the implant site.  241 
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)LJXUHVKRZVUHSUHVHQWDWLYHLPDJHVRI3.&ĮSRVLWLYHURGELSRODUFHOOVLQZLOG-type 242 
(WT) (Figure 1B) and RCS rat retinas. An unimplanted RCS retina is shown in Figure 1F. The 243 
unimplanted and the implanted RCS retinas exhibited atrophy of rod bipolar cell dendritic tufts 244 
relative to WT. In implanted retinas, this was the case both within and outside implant sites. In 245 
all RCS retinas, rod bipolar cells retained the other aspects of their characteristic morphology; 246 
their somas were located near the outer margin of the INL and axon terminals in the distal IPL. 247 
In addition, they persisted across the retina, including within the implant site regardless of 248 
device design (Figure 1C, G). There were no apparent disruptions of rod bipolar cell morphology 249 
between implant site, adjacent, and distal sites for both bPVA and mPVA implants (compare 250 
Figure 1 C,G to D,H to E,I). 251 
Implantation of subretinal devices in S334ter-3 rats had no effect on rod bipolar cell 252 
morphology. Unimplanted S334ter-3 control retinas (Figure 2E) showed a complete loss of rod 253 
bipolar cell dendritic arbors, disorganization of their somas, and a considerably thinner INL 254 
compared to WT (Figure 2A); demonstrating a more advanced retinal degeneration compared to 255 
RCS rats (Figures 1F and 2E). Similarly, S334ter-3 morphology of rod bipolar cells was 256 
comparable regardless of PVA design (Figure 2B-D and 2F-H). S334ter- 3 rod bipolar cells 257 
retained their characteristic morphology with somas near the outer margin of the INL and axon 258 
terminals in the distal IPL. In addition, there was no apparent disruption of rod bipolar cell 259 
morphology between implant site, adjacent, and distal sites in the S334ter-3 rat (Figures 2B-D 260 
and F-H), UHJDUGOHVVRIGHYLFHGHVLJQ4XDQWLILFDWLRQRIWKHOHQJWKRI3.&ĮODEHOHGURGELSRODU261 
cells in S344ter-3 rats showed no significant differences between mPVA and bPVA implanted 262 
rats or retinal location (Figure 3A; Two-way repeated ANOVA, p>0.05).  263 
3.2 Cholinergic amacrine cells intact with implantation of PVA devices 264 
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RCS and S334ter-3 sections were labeled with ChAT to explore the organization of the 265 
cholinergic amacrine cells and the laminar bands that their processes form in the IPL (Figure 4). 266 
The pattern of ChAT expression indicated that cholinergic amacrine cells survive within the 267 
implant site and both their somas and processes maintain WT IPL lamination patterns, with cell 268 
bodies in both the ganglion cell layer (GCL) and the innermost layer of the INL, and stratified 269 
processes within sublaminae a and b (Figure 4). RCS and S334ter-3 tissue showed identical 270 
expression patterns in unimplanted control, implanted, adjacent, and distal retinal tissue with 271 
implantation of the bPVA (Figure 4B-I). mPVA-implanted retinas maintained this typical pattern 272 
(data not shown). Counts of ChAT labeled nuclei in S334ter-3 eyes in both the INL and ganglion 273 
cell layer had a trend towards being lower in mPVA  than bPVA, but did not differ statistically 274 
(Figure 3C, 3D; Two-way repeated ANOVA, p=0.111 and p = 0.112, respectively). ChAT 275 
expression pattern also was examined en face in retinal flat mounts in a subset of RCS rats 276 
(Figure 5). The general distribution of ChAT-labeled cells was consistent between control and 277 
both mPVA implanted retinas for ChAT-labeled cells in both the INL and ganglion cell, which 278 
tiled the retina in a mosaic fashion as expected (Figure 5A vs 5B and 5C vs 5D, respectively).  279 
3.3 Mller cell glial reaction within normal limits after implantation 280 
 Glial reaction within RCS and S334ter-3 retina was evaluated using expression of GFAP 281 
(Figure 6). RCS age-matched unimplanted retinas (Figure 6A) displayed strong GFAP labeling 282 
in Mller glial processes that extended from the nerve fiber layer (NFL) to the partially 283 
degenerated ONL. In bPVA implanted RCS retinas at 4 weeks post implantation (Figure 6B-D), 284 
the glial reaction within the implant site was similar to the reaction in adjacent and distal regions; 285 
we observed little to no additional glial scarring around the implant (Figure 6B). In fact, in many 286 
cases, GFAP labeling appeared to be less pronounced at the implant site (Figure 6B) relative to 287 
distal areas (Figure 6D). Similar results were found with mPVA devices (data not shown). 288 
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 S334ter-3 age-matched unimplanted retinas showed intense GFAP labeling at the outer 289 
edge of the INL that was not seen in RCS retina (Figure 6A, E, I). This is consistent with the 290 
faster degeneration in this model and the formation of a glial seal that occurs after total 291 
photoreceptor degeneration (Jones et al., 2003). While glial reaction was widespread, 292 
persistent, and uniform in all S334ter-3 tissue, there was no noticeable difference in expression 293 
of GFAP by Mller glia in bPVA implanted retinas adjacent or distal to the implants (Figure 6J-294 
L). Although the spatial extent of GFAP reaction was similar in mPVA implanted retinas (Figure 295 
6F-H), we observed a significant increase in GFAP intensity in mPVA devices compared to 296 
bPVA (Figure 3B; Two-way repeated ANOVA, main effect of device, F(1, 15) = 14.38, p=0.02; 297 
Figure 3B). The differences were greatest over the implant regions with bPVA-implanted retinas 298 
having less GFAP immunoreactivity.   299 
4. Discussion 300 
 The use of subretinal prostheses for the restoration of vision in patients with RP or AMD 301 
depends upon an intact inner retina (O'Brien et al., 2012). Thus, it is critical that implantation of 302 
a subretinal device does not cause a loss of inner retinal cells or excessive gliosis/fibrosis, as 303 
both would interfere with the retinal-prosthesis interface. We have shown that a functional 304 
connection that requires synaptic transmission within the inner retina drives PVA evoked 305 
responses in the superior colliculus (Fransen et al., 2014). Here we show that the morphological 306 
basis for this connectivity is an intact inner retina in subretinally-implanted m- and bPVA 307 
devices. In addition, we show that morphology is maintained in two RP rat models, one with 308 
direct photoreceptor degeneration, the other with RPE dysfunction induced photoreceptor 309 
degeneration. This indicates that the effect we observe is general. We assessed rod bipolar 310 
cells because they represent the primary transmission pathway from the PVA to the RGCs and 311 
cholinergic amacrine cells because they are one of the most numerous amacrine cells and their 312 
processes form well known sublaminae in the the IPL. Together the two measures provide a 313 
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general assessment of inner retinal cell organization. While it is well-established that the 314 
degenerating retina undergoes remodeling when all photoreceptors are lost (Gargini et al., 315 
2007; Marc et al., 2003; Strettoi et al., 2002), we show that in these models, rod bipolar cells 316 
and cholinergic amacrine cells within the implant site continue to exhibit typical and well-317 
preserved morphology. Both their somata and processes within the IPL show normal 318 
localization and lamination. Previous studies show that normal retinas respond to both acute 319 
epiretinal electrical stimulation (Ray et al., 2009; Ray et al., 2011), or chronic subretinal 320 
implantation (Chow et al., 2001; Pardue et al., 2001; Tamaki et al., 2008; Yu et al., 2009) with 321 
an upregulation of GFAP expression and degenerative changes to the dendrites of rod bipolar 322 
cells. One study in which photosensitive dye-coupled film was subretinally implanted into RCS 323 
UDWH\HVVKRZHGSUHVHUYDWLRQZLWKLQWKHLPSODQWVLWHRIURGELSRODUFHOOPRUSKRORJ\YLD3.&Į324 
labeling (Alamusi et al., 2013), consistent with the findings we report here.  325 
The increase in GFAP labeling in all unimplanted RCS and S334ter-3 retinas compared 326 
to WT (images not shown) is consistent with previous reports on retinal remodeling during 327 
degeneration (Marc  and Jones, 2003; Zhao et al., 2012). Importantly, GFAP labeling in and 328 
around the implant site was similar to distal areas, suggesting that the glial reaction was not 329 
augmented by the presence of the PVA. Previous immunohistochemical studies of subretinal 330 
implants in animals with normal retinas have shown an increase in GFAP expression within the 331 
implant site (Chow et al., 2001; Pardue et al., 2001; Tamaki et al., 2008; Yu et al., 2009). It is 332 
feasible that any upregulation in GFAP due to implantation is masked when extensive gliosis 333 
due to photoreceptor degeneration is already present. Quantification of GFAP 334 
immunofluorescence showed a significant decrease in S334ter-3 retinas implanted with bPVAs 335 
compared to mPVAs.  This may indicate that the gap design of the bPVA is more biocompatible 336 
with the retina and reduces the stress response. As the PVA devices are active and present 337 
electrical current to the underlying inner retina in response to light, it is possible that GFAP 338 
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expression in the Mller glia is tempered by neuroprotective effects of subretinal electrical 339 
stimulation, which have been characterized previously (Ciavatta et al., 2013; Pardue et al., 340 
2005a; Pardue et al., 2005b).  341 
The persistence of inner retinal cells and their intact organization under the implanted 342 
device are consistent with our finding that PVA evoked responses are retained in the superior 343 
colliculus and require inner retinal synaptic transmission (Fransen et al., 2014). Structural 344 
integrity is critical to the success of function using this subretinal approach to visual restoration. 345 
The presence of normal IPL sublamination suggests that other circuits that modulate the 346 
excitatory signal are retained and may provide even better RGC and central signals. When 347 
translated to the clinic, implantation will be performed at mid to late stage of photoreceptor 348 
degeneration, similar to the implantation stages used here in the RCS and S334ter-3 rats, 349 
respectively. The morphology of the retina implanted with both PVAs was similar, which also is 350 
consistent with the functional results (Fransen et al., 2014) suggesting good compatibility at 351 
both stages of degeneration.   352 
The development of the next-generation bPVA is intended to improve upon the design of 353 
the mPVA device, which has already been implanted in human patients (Chow et al., 2010; 354 
Chow et al., 2004). Bipolar design of the pixel electrodes provides much tighter confinement of 355 
electric field, and appears to improve spatial resolution, compared to monopolar arrangement in 356 
mPVAs (Fransen et al., 2014). Our comparisons between mPVA- and bPVA-implanted retinas 357 
and the reduced glial reaction in the retinas implanted with the bPVA device with the gaps 358 
between pixels suggests improved biocompatibility and may indicate a longer duration of the 359 
interface between the device and the retina, which needs to be tested empirically.  360 
5. Conclusions  361 
16 
We found that both mPVA and bPVA devices implanted into the subretinal space were 362 
well tolerated by the inner retina in two rat models of RP with regard to rod bipolar, cholinergic 363 
amacrine, and Mller cell morphology. This initial analysis could be complemented with assays 364 
of other cell types (such as cone bipolar cells, horizontal cells as well as other amacrine cell 365 
classes). Other functional analyses could be aimed at examining the RGC responses and the 366 
timing and spatial distribution of their excitatory and inhibitory inputs. With our findings this 367 
would provide a complete understanding of the morphological and functional status of the inner 368 
retina in contact with the prosthesis.   369 
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Table 1: Primary antibodies used in this study to characterize inner retinal health. 377 
Antigen Antiserum Source Working 
Dilution 
Cellular Target 
3.&Į Polyclonal 
rabbit anti-
3.&Į 
Santa Cruz 
Biotechnology, 
Inc., Dallas, TX 
1:2000 Rod bipolar 
cells 
GFAP Polyclonal 
rabbit anti-
GFAP 
Abcam, 
Cambridge, MA 
1:500 Glial reaction in 
retinal Mller 
cells 
ChAT Polyclonal goat 
anti-ChAT 
Millipore, 
Billerica, MA 
1:100 Cholinergic 
amacrine cells 
 378 
Figures Captions 379 
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Figure 1. A) Sample fundus image of an RCS rat eye implanted subretinally with an mPVA. 380 
White dotted line indicates location of the cut made in the superior to inferior plane bisecting the 381 
posterior eye cup into implanted and non-LPSODQWHGKDOYHV³,PSODQWHG´UHJLRQLVLQGLFDWHGE\382 
WKHEOXHOLQH7KHDUHDLPPHGLDWHO\³DGMDFHQW´WRWKHLPSODQWVLWHLVVKRZQE\WKHUHGOLQH7KH383 
green line displays an area opposite the implant within the non-implanted half, referred to as a 384 
³GLVWDO´DUHD7KHLPSODQWLVPPLQGLDPHWHU3.&ĮODEHOLQJLQUHWLQDOFURVV-sections from WT 385 
rats (B), unimplanted control RCS rats at 2 months of age (F), RCS rats implanted from 4 to 8 386 
weeks postnatal with a bPVA (C-E) and or mPVA (G-I). Rod bipolar cells are present with well-387 
preserved morphology and localization at the implant site (C and G) relative to adjacent (D and 388 
H) and GLVWDO(DQG,UHJLRQV,PSODQWHGH\HVVKRZ3.&ĮODEHOLQJFRQVLVWHQWZLWKWKDWRIDJH-389 
matched unimplanted RCS controls (F). Wild-type retinas (B) appear to exhibit more intact 390 
dendritic tufts, but somata and axon terminal localization is comparable to that in RCS tissue. 391 
Insets 1B, 1C, 1 F & 1G show magnified images of the dendritic tufts in the OPL. ONL=outer 392 
nuclear layer, OPL=outer plexiform layer, INL=inner nuclear layer, IPL=inner plexiform layer, 393 
GCL=ganglion cell layer. Scale bar=50µm. 394 
Figure 23.&ĮODEHOLQJLQUHWLQDOFURVV-sections from S334ter-3 rats implanted with a bPVA (B-395 
D, implanted from 7 to 27 weeks postnatal) or mPVA (F-H, implanted from 6 to 27 weeks 396 
postnatal). Implanted sections (B and F) show rod bipolar cell morphology that is comparable to 397 
that in adjacent (C and G) and distal (D and H) areas. The morphology and localization of these 398 
sections is consistent with that seen in age-matched unimplanted S334ter-3 controls (E). 399 
However, all S334ter-3 tissues exhibit virtually complete loss of the ONL and rod bipolar cell 400 
dendrites, both of which are still evident in wild-type retina (A). Scale bar=50µm. 401 
Figure 33.&Į*)$3DQG&K$7ODEHOLQJTXDQWLILFDWLRQ7KHrelative OHQJWKRI3.&Į-labeled 402 
bipolar cells (A) did not show significant differences between retinal region or implant types. The 403 
intensity of GFAP immunoreactivity (B) did not show significant differences between the retinal 404 
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location within each implant type, but did show a difference between implant types (Two-way 405 
repeated ANOVA, F(1, 15) = 14.38 p =  0.02, n = 6). Immunoreactivity was normalized to the 406 
GLVWDOSRVLWLRQIRUWKH3.&ĮDnd GFAP labeling. ChAT immunoreactive cell counts did not show 407 
significant differences between retinal location or implant type for either INL placed (C) or 408 
displaced (D) cholinergic amacrine cells. Error bars represent standard error of the mean. 409 
Figure 4. ChAT labeling in retinal cross-sections from RCS eyes (C-E, implanted from 4 to 8 410 
weeks postnatal) and S334ter-3 eyes (G-I, implanted from 7 to 27 weeks postnatal) with bPVA 411 
devices. Both RCS (B-E) and S334ter-3 sections (F-I), like wild-type (A), show typical 412 
cholinergic amacrine cell morphology with somata in the INL and GCL and processes in a dual-413 
lamination pattern within the IPL. ChAT labeling patterns in implanted areas (C and G) are 414 
identical to those in adjacent (D and H), distal (E and I), Scale bar=50µm. 415 
Figure 5. ChAT-labeled retinal flat mounts from RCS rats implanted from 4 to 8 weeks postnatal 416 
with an mPVA device (C and D) compared to unimplanted control eyes (A and B). En face view 417 
of unimplanted INL placed (A) and implanted INL placed (C) ChAT positive amacrine cells 418 
shows similar cholinergic amacrine cell distribution with consistent density. Similarly, labelling 419 
patterns of ChAT positive amacrine cells in the ganglion cell layer were consistent between 420 
unimplanted (B) and implanted (D) retinas. Scale bar=50µm.  421 
 422 
Figure 6. GFAP labeling in retinal cross-sections from RCS (B-D) with bPVA and S334ter-3 423 
eyes with mPVA (F-H) and bPVA (K-L) devices. RCS were implanted 4 to 8 weeks postnatally, 424 
while the S334ter-3 animals were implanted at 12 to 32 weeks. Glial reaction is widespread in 425 
all RCS tissue (A-D), but implanted areas (B) do not show increased GFAP labeling in 426 
comparison with adjacent (C), distal (D), and age-matched unimplanted control (A) sections. 427 
Similar to RCS tissue, S334ter-3 sections (E-L) show widespread gliosis due to photoreceptor 428 
degeneration. However, GFAP labeling is not augmented in implanted regions (F and J) relative 429 
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to adjacent (G and K), distal (H and L), and age-matched unimplanted control section (E). 430 
S334ter-3 retinas display a characteristic glial seal above the INL, not seen in wild-type retinas 431 
(data not shown), consistent with advanced photoreceptor degeneration. NFL=nerve fiber layer. 432 
Scale bar=50µm. 433 
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Abstract:  24 
 Photovoltaic arrays (PVA) implanted into the subretinal space of patients with retinitis 25 
pigmentosa (RP) are designed to electrically stimulate the remaining inner retinal circuitry in 26 
response to incident light, thereby recreating a visual signal when photoreceptor function 27 
declines or is lost. Preservation of inner retinal circuitry is critical to the fidelity of this transmitted 28 
signal to ganglion cells and beyond to higher visual targets. Post-implantation loss of retinal 29 
interneurons or excessive glial scarring could diminish and/or eliminate PVA-evoked signal 30 
transmission. As such, assessing the morphology of the inner retina in RP animal models with 31 
subretinal PVAs is an important step in defining biocompatibility and predicting success of signal 32 
transmission. In this study, we used immunohistochemical methods to qualitatively and 33 
quantitatively compare inner retinal morphology after the implantation of a PVA in two RP 34 
models: the Royal College of Surgeons (RCS) or transgenic S334ter-line 3 (S334ter-3) 35 
rhodopsin mutant rat. Two PVA designs were compared. In the RCS rat, we implanted devices 36 
in the subretinal space at 4 weeks of age and histologically examined them at 8 weeks of age 37 
and found inner retinal morphology preservation with both PVA devices. In the S334ter-3 rat, we 38 
implanted devices at 6 to 12 weeks of age and again, inner retinal morphology was generally 39 
preserved with either PVA design 16 to 26 weeks post implantation. Specifically, the length of 40 
rod bipolar cells and numbers of cholinergic amacrine cells were maintained along with their 41 
characteristic inner plexiform lamination patterns. Throughout the implanted retinas we found 42 
nonspecific glial reaction, but none showed additional glial scarring at the implant site. Our 43 
results indicate that subretinally implanted PVAs are well-tolerated in rodent RP models and that 44 
the inner retinal circuitry is preserved, consistent with our published results showing implant-45 
evoked signal transmission.  46 
Keywords: retina, prosthetic, bipolar cells, amacrine cells, Mller glial cells  47 
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1. Introduction 48 
 Retinitis pigmentosa (RP) and age-related macular degeneration (AMD) are leading 49 
causes of irreversible blindness worldwide (Hartong et al., 2006). In these diseases, vision loss, 50 
regardless of underlying etiology, results from degeneration of retinal photoreceptors. 51 
Remodeling of the inner retina occurs in late stages of disease (Jones and Marc, 2005; Marc 52 
and Jones, 2003; Marc et al., 2007; Strettoi et al., 2002), but photoreceptor degeneration leaves 53 
the neurons and circuitry of the inner retina relatively intact for extended periods of time 54 
(Humayun et al., 1999; Jones et al., 2003; Marc and Jones, 2003; Marc et al., 2007; Strettoi et 55 
al., 2002; Strettoi et al., 2003).   56 
One promising approach that targets the remaining retinal circuitry to restore lost vision 57 
uses prosthetic devices to functionally replace photoreceptors. Several different designs and 58 
placement strategies are currently being evaluated. Epiretinal placement and stimulation of the 59 
retinal ganglion cells (RGC) should require algorithms to selectively achieve information 60 
transmission (Jensen et al., 2005; Humayun et al., 2012). Suprachoroidal implants (Cicione et 61 
al., 2012; Kanda et al., 2004; Morimoto et al., 2011; Wong et al., 2009; Yamauchi et al., 2005) 62 
and subretinal microphotodiode arrays (Chow et al., 2001; Mathieson et al., 2012; Rizzo, 2011; 63 
Zrenner et al., 1999) are designed to directly stimulate bipolar cells and theoretically utilize 64 
network-mediated retinal stimulation, preserving the integrative properties of second order 65 
neurons in the inner plexiform layer (IPL) (Asher et al., 2007; Wang et al., 2012). Other 66 
strategies utilize optogenetics to confer light sensitivity to bipolar or RGCs (Bi et al., 2006; 67 
Busskamp et al., 2012; Garg and Federman, 2013; Isago et al., 2012; Lin et al., 2008; Tomita et 68 
al., 2007) to directly stimulate retinal tissues.  69 
Subretinally placed photovoltaic arrays (PVAs) provide targeted stimulation to the inner 70 
nuclear layer (INL) (Fransen et al., 2014) due to their current density distribution and size 71 
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(Mathieson et al. 2012). Because bipolar cells are interneurons that connect photoreceptors to 72 
RGCs they are involved in signal transmission with PVAs. Retention of these cells and 73 
formation of a functional retinal-prosthetic interface would aid in visual restoration. For this to 74 
occur there must be a high level of biocompatibility between the retina and prosthesis. As such, 75 
measures of the integrity of the bipolar cells and other retinal constituents are critical 76 
components to the evaluation of the success of any subretinal prosthetic.  77 
 Previous studies have attempted to characterize the condition of implanted and/or 78 
electrically stimulated retinal tissue histologically and immunohistochemically (Alamusi et al., 79 
2013; Chow et al., 2001; Pardue et al., 2001; Ray et al., 2009; Ray et al., 2011; Tamaki et al., 80 
2008). However, many of these studies have examined the effects only of certain aspects of the 81 
treatment paradigm, such as acute electrical stimulation or biocompatibility of a prosthetic 82 
device in wild-type animals that do not exhibit degenerative pathology. In this study, we 83 
examined retinal morphology after implantation of two generations of subretinal silicon devices 84 
in two RP rat models. We compared a monopolar PVA (mPVA) with no perforations (Chow et 85 
al., 2001) to a bipolar PVA (bPVA), which includes bipolar pixels separated by 5 ȝP gaps 86 
(Mathieson et al., 2012). Photovoltaic pixels in monopolar devices have individual active 87 
electrodes, but share a common large return electrode on the back side of the implant. Bipolar 88 
pixels are composed of 3 photodiodes in series, connected between the active electrode in the 89 
center of the pixel and a return electrode surrounding each pixel (Mathieson et al., 2012). All 90 
devices in the present study were photoactive. The bPVA gaps enhance proximity of the 91 
electrodes to inner retinal neurons and allow diffusion of extracellular milieu through the implant 92 
(Adkins et al., 2013; Mathieson et al., 2012). Since the subretinal PVA stimulates retinal 93 
neurons that are within close proximity to the electrode (Fransen et al., 2014), we focused our 94 
analysis on inner retinal cells that are likely activated by the PVA device. Rod bipolar cells and 95 
cholinergic amacrine cells represent well defined populations of cells with robust cellular 96 
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markers to assess overall inner retinal health. We also assessed glial reaction in tissues within 97 
and distal to the implant site from 16 to 26 weeks post implantation in the S334ter-3 and 4 98 
weeks post implantation in the RCS rat. Our results suggest that both the mPVA and bPVA 99 
designs are well tolerated and preserve the necessary inner retinal circuitry that underlie the 100 
transmission of signals to the RGCs and beyond (Fransen et al., 2014). 101 
2. Methods 102 
2.1 Animals and Experimental Groups 103 
 All animal procedures were approved by the Institutional Animal Care and Use 104 
Committee and conformed to the ARVO Statement for the Use of Animals in Ophthalmology 105 
and Vision Research. Two models of RP were used: the Royal College of Surgeons (RCS) and 106 
S334ter-3 rats from an in-house breeding colony originated from breeders donated by Dr. 107 
Matthew LaVail (University of California, San Francisco) (LaVail et al., 1975; Mullen and LaVail, 108 
1976).  109 
The RCS rats (n=4) were implanted binocularly at 4 weeks of age and terminated 4 110 
weeks post-implantation. RCS rats exhibit a moderate rate of photoreceptor degeneration; 111 
approximately 50% of the initial ONL thickness was present at the age of implantation (LaVail 112 
and Battelle, 1975). Four eyes were implanted with an mPVA device and 4 with a bPVA device. 113 
The eyes were divided such that all bPVA-implanted eyes were processed as frozen sections 114 
for retinal cross-sections and half the mPVA eyes processed similarly with the remaining 115 
prepared as retinal flat mounts. 116 
 S334ter-3 rats were implanted monocularly (right eye) with either an mPVA (n=4) or a 117 
bPVA (n=7) from 6 to 12 weeks of age and were terminated at 22 to 32 weeks of age (16-26 118 
weeks of implantation). Monocular implantation accommodated superior colliculus recordings 119 
that are reported elsewhere (Fransen et al., 2014). The S334ter-3 is a rapid degeneration model 120 
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and most photoreceptors had degenerated at the time of implantation (McGill et al., 2012). All 121 
S334ter-3 eyes were processed as frozen sections. Additional cross sections were analyzed 122 
from three age-matched unimplanted control eyes from each RP strain, as well as 3 eyes from 123 
8-week-old Long Evans wild-type rats acquired from Charles River.  124 
2.2 Overview of Devices 125 
Two types of PVA were explored: mPVA and bPVA (Mathieson et al., 2012; Pardue et 126 
al., 2005b). mPVA devices, provided by Optobionics, Inc (Glen Ellyn, IL), were fabricated using 127 
previously described thin-film fabrication methods (Chow et al., 2001). The mPVA is a 1 mm 128 
diameter silicon disk, 25 ȝPthick, containing 1200 microphotodiodes with active electrodes on 129 
one face and a common return electrode on the back, both coated with iridium oxide (Chow et 130 
al., 2001).  7KHE39$GHYLFH¶VSKRWRYROWDLFDUUD\VZHUHFRPSRVHGRIWULSOH-diode pixels 131 
fabricated on a silicon wafer.  Each pixel contains an active electrode in its center and a return 132 
electrode at the circumference. Upon illumination with a pulse of light, each pixel generates a bi-133 
phasic pulse of electric current flowing through the tissue between electrodes, primarily 134 
stimulating the inner nuclear layer (INL) cells (Fransen et al., 2014). Electrodes were coated in 135 
iridium oxide and the details of manufacturing methods of the bPVA were published previously 136 
(Wang et al., 2012). Five-ȝPwide gaps were etched between adjacent pixels for electrical 137 
isolation and to improve nutrients flow through the implant (Mathieson, et al. 2012). The bPVA 138 
device measured 0.8 x 1.2 mm and was 30-ȝPthick. bPVA devices were left in retinal tissue for 139 
histological analysis due to tissue destruction caused by removal. 140 
 141 
2.3 Surgical Procedure 142 
 The surgical methods employed for implantation of the PVAs into the subretinal space 143 
have been described previously (Pardue et al., 2005b). Briefly, rats were anesthetized 144 
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[ketamine (60 mg/kg) and xylazine (7.5 mg/kg)] and placed into a sterile field. A traction suture 145 
was made at the superior limbus and the eye was rotated inferiorly. A ~1.0 mm incision was 146 
made in the superior globe reaching the vitreous. The eye was hydrated with a drop of saline, 147 
and a 10 minute waiting period was observed which allowed the retina to detach from the RPE. 148 
The PVA was then slid into the subretinal space with the electrodes in contact with the retina. 149 
Successful subretinal placement was confirmed via fundus examination and subsequent 150 
spectral domain-ocular coherence tomography (SD-OCT) imaging (Heidelberg HRA+OCT, 151 
Carlsbad, CA) (Fransen et al., 2014).  Implants rested in the superior-temporal retina from 0.5 to 152 
1 mm from the optic nerve head.   153 
2.4 Immunohistochemistry 154 
2.4.1 Cross-sections 155 
Following anesthesia [ketamine (60 mg/kg)/xylazine (7.5 mg/kg)] and sacrifice [390 156 
mg/mL pentobarbital sodium (Euthasol, Virbac AH, Inc., Fort Worth, TX)], eyes were 157 
immediately enucleated and fixed in 4% paraformaldehyde for 30 minutes. The posterior eyecup 158 
was bisected in the superior/inferior plane near the optic nerve, ensuring that the entire implant 159 
was intact and present in only one of the two resulting halves (Figure 1A). mPVA devices were 160 
gently extracted from the subretinal space using hydrodissection. bPVAs, which contain gaps 161 
through which the retinal tissue migrates (Palanker et al., 2004), were left in place to preserve 162 
retinal morphology around the implant. The tissue was cryoprotected overnight in 30% sucrose 163 
in 0.1M PBS and frozen in embedding medium (O.C.T. Tissue-Tek¨, Sakura Finetek, Tokyo). 164 
Retinal sections in the superior/inferior plane (20-30 ȝP) were cut on a cryostat and thaw-165 
mounted on glass slides. Sections containing the implant site were mounted on the same slide 166 
with sections from the corresponding non-LPSODQWHGKDOIUHIHUUHGWRDV³GLVWDO´WLVVXHVRWKDW167 
both sections received equal reagent exposure. 168 
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Table 1 lists the antibodies used, along with working dilutions and sources. Rod bipolar 169 
cells were labeled with anti-prRWHLQNLQDVH&DOSKDVXEXQLW3.&Į.RVDNDHWDO0OOHU170 
glial reaction in response to ocular stress was assessed with antibodies to glial fibrillary acidic 171 
protein (GFAP) (Bringmann et al., 2006). Finally, cholinergic amacrine cells and IPL lamination 172 
patterns were visualized with anti-choline acetyltransferase (ChAT) antibodies (Dijk and 173 
Kamphuis, 2004). The incubation protocol has been described previously (Lee et al., 2008). 174 
Briefly, following a wash in 1.0 M PBS slides were blocked for 1 hour at room temperature (10% 175 
donkey serum, 1% BSA, and 1% Triton X-100 in 1.0 M PBS). Primary and secondary antibodies 176 
were diluted in 1.0 M PBS containing 0.5% Triton X-100. Sections were incubated with primary 177 
antibodies overnight at 4¡C and secondary antibodies for 2 hours at room temperature. 178 
Fluorescent secondary antibodies included donkey-anti-rabbit-DyLight¨ 488 (Abcam, 179 
Cambridge, MA) and donkey-anti-goat-DyLight¨ 594 (Abcam, Cambridge, MA), both diluted 180 
1:300. Sections were stained with DAPI, mounted with mounting medium (VectaShield¨ Hard 181 
Set, Vector Laboratories, Inc., Burlingame, CA), and coverslipped.  182 
 Sections were visualized and images taken on a confocal microscope (Eclipse Ti 183 
microscope with D-Eclipse C1 confocal controller, Nikon, Tokyo). Z-stack images spanning the 184 
section thickness at 1 ȝPintervals were captured using a 40 X oil immersion lens directly under 185 
WKHLPSODQWVLWH³LPSODQWHG´LPPHGLDWHO\DGMDFHQWWRWKHLPSODQWVLWH³DGMDFHQW´DQG³GLVWDO´186 
tissue from the non-implanted portion of the eye (see Figure 1A). Images of unimplanted control 187 
tissue were acquired from central, superior retinal sections. The Z-stack images were 188 
condensed into max-intensity volume projections and processed using commercial software 189 
,PDJH-1,+%HWKHVGD0'DQG3KRWRVKRS$GREH6\VWHPV,QF6DQ-Rse, CA). For 190 
comparisons of cross sections, extended-focus confocal images were composed of a stack of 191 
26 images along the z-axis. ChAT flat mounted extended-focus confocal images were 192 
comprised of a stack of 5 planes, each 1 ȝPthick. Pinhole size, gain, photo multiplier, and 193 
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offset of the confocal microscope were standardized within experimental groups. Brightness and 194 
contrast optimization was applied equally across all images, except images of GFAP-labeled 195 
sections in which no optimization was performed. 196 
2.4.2 Quantification  197 
Digital confocal cross-sections were analyzed using an image program (Image J, 198 
National Institute of Health, Bethesda, MA). Cross-sections of immuno-labeled S334ter-3 199 
retinas, implanted with either mPVA or bPVA were quantified in the following ways: 1) the length 200 
RI3.&ĮODEHOHGURGELSRODUFHOOVZHUHmeasured from the center of the soma to the axon 201 
terminals, 2) intensity of GFAP immunofluorescence was measured, and 3) the number of INL-202 
placed and displaced (in RGC layer) ChAT-positive amacrine nuclei were counted. For each 203 
quantification, at least 2 sections from 2-4 retinas were analyzed. Triplicate measurements of 204 
rod bipolar cells from summed z-VWDFN3.&Į-labeled images were made on each section and 205 
averaged.  GFAP immunoreactivity was quantified by measuring the intensity of a 55 x 40 ȝP206 
region of interest (ROI) beginning at the retinal ganglion cell layer extending into the inner 207 
SOH[LIRUPOD\HUDQGQRUPDOL]HGWRDEDFNJURXQGUHJLRQZLWKRXWWLVVXHRIVLPLODUVL]H3.&ĮDQG208 
GFAP data was normalized to the distal regions to compare implant designs between different 209 
ages.  ChAT-labeled z-stacks were summed and the number of ChAT positive nuclei was 210 
measured along a 150-ȝPlength on each section.  211 
Statistical comparisons between mPVA and bPVA devices from each retinal region were 212 
made with two-way repeated measures ANOVA using Holm-Sidak post-hoc comparisons 213 
(Sigmastat v3.5 ,Systat Software, San Jose, CA).   214 
2.4.3 Flat mounts 215 
A subset of RCS eyes was processed as flat mounts, as described previously (Bernstein 216 
and Guo, 2011), with the following modifications. Eyes were enucleated and fixed in 4% 217 
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paraformaldehyde for 2 hours. The posterior eye cups were digested in hyaluronidase (1mg/mL; 218 
Sigma-Aldrich, St. Louis, MO) diluted 1:500 in 1.0 M PBS for 30 minutes. The retinas were 219 
carefully dissected from the retinal pigment epithelium (RPE), washed twice in PBST (0.5% 220 
Triton X-100 in 1.0M PBS), and then frozen in PBST at -80¡C for 15 minutes. After thawing 221 
slowly at room temperature, the retina was washed twice in PBST, blocked (10% donkey serum, 222 
0.25% Triton X-100 in 1.0M PBS) for 4 hours at room temperature, and incubated in anti-ChAT 223 
antibody (Table 1) overnight at 4¡C. After 3 washes in PBST, donkey-anti-goat-DyLight¨ 594 224 
secondary antibody (1:300; Abcam, Cambridge, MA) was applied for 1 hour at room 225 
temperature. Following additional washes, retinas were stained with DAPI, cut into a cloverleaf 226 
shape, and flattened on glass slides with the RGC layer face up. The retinas were mounted with 227 
mounting medium (VectaShield¨ Hard Set, Vector Laboratories, Inc., Burlingame, CA) and 228 
coverslipped. 229 
 The flat mounts were imaged using the confocal system, as described above, to 230 
generate Z-stack images over the implant site and distal regions of the same retina. 3D 231 
recreations were assembled and rotated using the 3D Viewer Plugin (ImageJ, NIH, Bethesda, 232 
0'&RQWUDVWDQGEULJKWQHVVZHUHRSWLPL]HGHTXDOO\DFURVVLPDJHV3KRWRVKRS$GREH233 
Systems, Inc., San Jose, CA). 234 
3. Results 235 
3.1 Rod bipolar cells maintained in both implant designs and RP models  236 
 5RGELSRODUFHOOVZHUHODEHOHGIRU3.&ĮLQERWK5&6DQG6WHU-3 rat eyes implanted 237 
with either PVA design. Figure 1A shows a fundus image of an mPVA in an RCS rat and the 238 
superimposed colored lines indicate the areas of the retina sampled in each of the subsequent 239 
figures. Blue indicates the area within the implant site, red the area adjacent to and green the 240 
area distal to the implant site.  241 
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)LJXUHVKRZVUHSUHVHQWDWLYHLPDJHVRI3.&ĮSRVLWLYHURGELSRODUFHOOVLQZLOG-type 242 
(WT) (Figure 1B) and RCS rat retinas. An unimplanted RCS retina is shown in Figure 1F. The 243 
unimplanted and the implanted RCS retinas exhibited atrophy of rod bipolar cell dendritic tufts 244 
relative to WT. In implanted retinas, this was the case both within and outside implant sites. In 245 
all RCS retinas, rod bipolar cells retained the other aspects of their characteristic morphology; 246 
their somas were located near the outer margin of the INL and axon terminals in the distal IPL. 247 
In addition, they persisted across the retina, including within the implant site regardless of 248 
device design (Figure 1C, G). There were no apparent disruptions of rod bipolar cell morphology 249 
between implant site, adjacent, and distal sites for both bPVA and mPVA implants (compare 250 
Figure 1 C,G to D,H to E,I). 251 
Implantation of subretinal devices in S334ter-3 rats had no effect on rod bipolar cell 252 
morphology. Unimplanted S334ter-3 control retinas (Figure 2E) showed a complete loss of rod 253 
bipolar cell dendritic arbors, disorganization of their somas, and a considerably thinner INL 254 
compared to WT (Figure 2A); demonstrating a more advanced retinal degeneration compared to 255 
RCS rats (Figures 1F and 2E). Similarly, S334ter-3 morphology of rod bipolar cells was 256 
comparable regardless of PVA design (Figure 2B-D and 2F-H). S334ter- 3 rod bipolar cells 257 
retained their characteristic morphology with somas near the outer margin of the INL and axon 258 
terminals in the distal IPL. In addition, there was no apparent disruption of rod bipolar cell 259 
morphology between implant site, adjacent, and distal sites in the S334ter-3 rat (Figures 2B-D 260 
and F-H), UHJDUGOHVVRIGHYLFHGHVLJQ4XDQWLILFDWLRQRIWKHOHQJWKRI3.&ĮODEHOHGURGELSRODU261 
cells in S344ter-3 rats showed no significant differences between mPVA and bPVA implanted 262 
rats or retinal location (Figure 3A; Two-way repeated ANOVA, p>0.05).  263 
3.2 Cholinergic amacrine cells intact with implantation of PVA devices 264 
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RCS and S334ter-3 sections were labeled with ChAT to explore the organization of the 265 
cholinergic amacrine cells and the laminar bands that their processes form in the IPL (Figure 4). 266 
The pattern of ChAT expression indicated that cholinergic amacrine cells survive within the 267 
implant site and both their somas and processes maintain WT IPL lamination patterns, with cell 268 
bodies in both the ganglion cell layer (GCL) and the innermost layer of the INL, and stratified 269 
processes within sublaminae a and b (Figure 4). RCS and S334ter-3 tissue showed identical 270 
expression patterns in unimplanted control, implanted, adjacent, and distal retinal tissue with 271 
implantation of the bPVA (Figure 4B-I). mPVA-implanted retinas maintained this typical pattern 272 
(data not shown). Counts of ChAT labeled nuclei in S334ter-3 eyes in both the INL and ganglion 273 
cell layer had a trend towards being lower in mPVA  than bPVA, but did not differ statistically 274 
(Figure 3C, 3D; Two-way repeated ANOVA, p=0.111 and p = 0.112, respectively). ChAT 275 
expression pattern also was examined en face in retinal flat mounts in a subset of RCS rats 276 
(Figure 5). The general distribution of ChAT-labeled cells was consistent between control and 277 
both mPVA implanted retinas for ChAT-labeled cells in both the INL and ganglion cell, which 278 
tiled the retina in a mosaic fashion as expected (Figure 5A vs 5B and 5C vs 5D, respectively).  279 
3.3 Mller cell glial reaction within normal limits after implantation 280 
 Glial reaction within RCS and S334ter-3 retina was evaluated using expression of GFAP 281 
(Figure 6). RCS age-matched unimplanted retinas (Figure 6A) displayed strong GFAP labeling 282 
in Mller glial processes that extended from the nerve fiber layer (NFL) to the partially 283 
degenerated ONL. In bPVA implanted RCS retinas at 4 weeks post implantation (Figure 6B-D), 284 
the glial reaction within the implant site was similar to the reaction in adjacent and distal regions; 285 
we observed little to no additional glial scarring around the implant (Figure 6B). In fact, in many 286 
cases, GFAP labeling appeared to be less pronounced at the implant site (Figure 6B) relative to 287 
distal areas (Figure 6D). Similar results were found with mPVA devices (data not shown). 288 
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 S334ter-3 age-matched unimplanted retinas showed intense GFAP labeling at the outer 289 
edge of the INL that was not seen in RCS retina (Figure 6A, E, I). This is consistent with the 290 
faster degeneration in this model and the formation of a glial seal that occurs after total 291 
photoreceptor degeneration (Jones et al., 2003). While glial reaction was widespread, 292 
persistent, and uniform in all S334ter-3 tissue, there was no noticeable difference in expression 293 
of GFAP by Mller glia in bPVA implanted retinas adjacent or distal to the implants (Figure 6J-294 
L). Although the spatial extent of GFAP reaction was similar in mPVA implanted retinas (Figure 295 
6F-H), we observed a significant increase in GFAP intensity in mPVA devices compared to 296 
bPVA (Figure 3B; Two-way repeated ANOVA, main effect of device, F(1, 15) = 14.38, p=0.02; 297 
Figure 3B). The differences were greatest over the implant regions with bPVA-implanted retinas 298 
having less GFAP immunoreactivity.   299 
4. Discussion 300 
 The use of subretinal prostheses for the restoration of vision in patients with RP or AMD 301 
depends upon an intact inner retina (O'Brien et al., 2012). Thus, it is critical that implantation of 302 
a subretinal device does not cause a loss of inner retinal cells or excessive gliosis/fibrosis, as 303 
both would interfere with the retinal-prosthesis interface. We have shown that a functional 304 
connection that requires synaptic transmission within the inner retina drives PVA evoked 305 
responses in the superior colliculus (Fransen et al., 2014). Here we show that the morphological 306 
basis for this connectivity is an intact inner retina in subretinally-implanted m- and bPVA 307 
devices. In addition, we show that morphology is maintained in two RP rat models, one with 308 
direct photoreceptor degeneration, the other with RPE dysfunction induced photoreceptor 309 
degeneration. This indicates that the effect we observe is general. We assessed rod bipolar 310 
cells because they represent the primary transmission pathway from the PVA to the RGCs and 311 
cholinergic amacrine cells because they are one of the most numerous amacrine cells and their 312 
processes form well known sublaminae in the the IPL. Together the two measures provide a 313 
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general assessment of inner retinal cell organization. While it is well-established that the 314 
degenerating retina undergoes remodeling when all photoreceptors are lost (Gargini et al., 315 
2007; Marc et al., 2003; Strettoi et al., 2002), we show that in these models, rod bipolar cells 316 
and cholinergic amacrine cells within the implant site continue to exhibit typical and well-317 
preserved morphology. Both their somata and processes within the IPL show normal 318 
localization and lamination. Previous studies show that normal retinas respond to both acute 319 
epiretinal electrical stimulation (Ray et al., 2009; Ray et al., 2011), or chronic subretinal 320 
implantation (Chow et al., 2001; Pardue et al., 2001; Tamaki et al., 2008; Yu et al., 2009) with 321 
an upregulation of GFAP expression and degenerative changes to the dendrites of rod bipolar 322 
cells. One study in which photosensitive dye-coupled film was subretinally implanted into RCS 323 
UDWH\HVVKRZHGSUHVHUYDWLRQZLWKLQWKHLPSODQWVLWHRIURGELSRODUFHOOPRUSKRORJ\YLD3.&Į324 
labeling (Alamusi et al., 2013), consistent with the findings we report here.  325 
The increase in GFAP labeling in all unimplanted RCS and S334ter-3 retinas compared 326 
to WT (images not shown) is consistent with previous reports on retinal remodeling during 327 
degeneration (Marc  and Jones, 2003; Zhao et al., 2012). Importantly, GFAP labeling in and 328 
around the implant site was similar to distal areas, suggesting that the glial reaction was not 329 
augmented by the presence of the PVA. Previous immunohistochemical studies of subretinal 330 
implants in animals with normal retinas have shown an increase in GFAP expression within the 331 
implant site (Chow et al., 2001; Pardue et al., 2001; Tamaki et al., 2008; Yu et al., 2009). It is 332 
feasible that any upregulation in GFAP due to implantation is masked when extensive gliosis 333 
due to photoreceptor degeneration is already present. Quantification of GFAP 334 
immunofluorescence showed a significant decrease in S334ter-3 retinas implanted with bPVAs 335 
compared to mPVAs.  This may indicate that the gap design of the bPVA is more biocompatible 336 
with the retina and reduces the stress response. As the PVA devices are active and present 337 
electrical current to the underlying inner retina in response to light, it is possible that GFAP 338 
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expression in the Mller glia is tempered by neuroprotective effects of subretinal electrical 339 
stimulation, which have been characterized previously (Ciavatta et al., 2013; Pardue et al., 340 
2005a; Pardue et al., 2005b).  341 
The persistence of inner retinal cells and their intact organization under the implanted 342 
device are consistent with our finding that PVA evoked responses are retained in the superior 343 
colliculus and require inner retinal synaptic transmission (Fransen et al., 2014). Structural 344 
integrity is critical to the success of function using this subretinal approach to visual restoration. 345 
The presence of normal IPL sublamination suggests that other circuits that modulate the 346 
excitatory signal are retained and may provide even better RGC and central signals. When 347 
translated to the clinic, implantation will be performed at mid to late stage of photoreceptor 348 
degeneration, similar to the implantation stages used here in the RCS and S334ter-3 rats, 349 
respectively. The morphology of the retina implanted with both PVAs was similar, which also is 350 
consistent with the functional results (Fransen et al., 2014) suggesting good compatibility at 351 
both stages of degeneration.   352 
The development of the next-generation bPVA is intended to improve upon the design of 353 
the mPVA device, which has already been implanted in human patients (Chow et al., 2010; 354 
Chow et al., 2004). Bipolar design of the pixel electrodes provides much tighter confinement of 355 
electric field, and appears to improve spatial resolution, compared to monopolar arrangement in 356 
mPVAs (Fransen et al., 2014). Our comparisons between mPVA- and bPVA-implanted retinas 357 
and the reduced glial reaction in the retinas implanted with the bPVA device with the gaps 358 
between pixels suggests improved biocompatibility and may indicate a longer duration of the 359 
interface between the device and the retina, which needs to be tested empirically.  360 
5. Conclusions  361 
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We found that both mPVA and bPVA devices implanted into the subretinal space were 362 
well tolerated by the inner retina in two rat models of RP with regard to rod bipolar, cholinergic 363 
amacrine, and Mller cell morphology. This initial analysis could be complemented with assays 364 
of other cell types (such as cone bipolar cells, horizontal cells as well as other amacrine cell 365 
classes). Other functional analyses could be aimed at examining the RGC responses and the 366 
timing and spatial distribution of their excitatory and inhibitory inputs. With our findings this 367 
would provide a complete understanding of the morphological and functional status of the inner 368 
retina in contact with the prosthesis.   369 
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 377 
Table 1: Primary antibodies used in this study to characterize inner retinal health. 378 
Antigen Antiserum Source Working 
Dilution 
Cellular Target 
3.&Į Polyclonal 
rabbit anti-
3.&Į 
Santa Cruz 
Biotechnology, 
Inc., Dallas, TX 
1:2000 Rod bipolar 
cells 
GFAP Polyclonal 
rabbit anti-
GFAP 
Abcam, 
Cambridge, MA 
1:500 Glial reaction in 
retinal Mller 
cells 
ChAT Polyclonal goat 
anti-ChAT 
Millipore, 
Billerica, MA 
1:100 Cholinergic 
amacrine cells 
 379 
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Figures Captions 380 
Figure 1. A) Sample fundus image of an RCS rat eye implanted subretinally with an mPVA. 381 
White dotted line indicates location of the cut made in the superior to inferior plane bisecting the 382 
posterior eye cup into implanted and non-LPSODQWHGKDOYHV³,PSODQWHG´UHJLRQLVLQGLFDWHGE\383 
WKHEOXHOLQH7KHDUHDLPPHGLDWHO\³DGMDFHQW´WRWKHLPSODQWVLWHLVVKRZQE\WKHUHGOLQH7KH384 
green line displays an area opposite the implant within the non-implanted half, referred to as a 385 
³GLVWDO´DUHD7KHLPSODQWLVPPLQGLDPHWHU3.&ĮODEHOLQJLQUHWLQDOFURVV-sections from WT 386 
rats (B), unimplanted control RCS rats at 2 months of age (F), RCS rats implanted from 4 to 8 387 
weeks postnatal with a bPVA (C-E) and or mPVA (G-I). Rod bipolar cells are present with well-388 
preserved morphology and localization at the implant site (C and G) relative to adjacent (D and 389 
H) and GLVWDO(DQG,UHJLRQV,PSODQWHGH\HVVKRZ3.&ĮODEHOLQJFRQVLVWHQWZLWKWKDWRIDJH-390 
matched unimplanted RCS controls (F). Wild-type retinas (B) appear to exhibit more intact 391 
dendritic tufts, but somata and axon terminal localization is comparable to that in RCS tissue. 392 
Insets 1B, 1C, 1 F & 1G show magnified images of the dendritic tufts in the OPL. ONL=outer 393 
nuclear layer, OPL=outer plexiform layer, INL=inner nuclear layer, IPL=inner plexiform layer, 394 
GCL=ganglion cell layer. Scale bar=50µm. 395 
Figure 23.&ĮODEHOLQJLQUHWLQDOFURVV-sections from S334ter-3 rats implanted with a bPVA (B-396 
D, implanted from 7 to 27 weeks postnatal) or mPVA (F-H, implanted from 6 to 27 weeks 397 
postnatal). Implanted sections (B and F) show rod bipolar cell morphology that is comparable to 398 
that in adjacent (C and G) and distal (D and H) areas. The morphology and localization of these 399 
sections is consistent with that seen in age-matched unimplanted S334ter-3 controls (E). 400 
However, all S334ter-3 tissues exhibit virtually complete loss of the ONL and rod bipolar cell 401 
dendrites, both of which are still evident in wild-type retina (A). Scale bar=50µm. 402 
Figure 33.&Į*)$3DQG&K$7ODEHOLQJTXDQWLILFDWLRQ7KHrelative OHQJWKRI3.&Į-labeled 403 
bipolar cells (A) did not show significant differences between retinal region or implant types. The 404 
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intensity of GFAP immunoreactivity (B) did not show significant differences between the retinal 405 
location within each implant type, but did show a difference between implant types (Two-way 406 
repeated ANOVA, F(1, 15) = 14.38 p =  0.02, n = 6). Immunoreactivity was normalized to the 407 
GLVWDOSRVLWLRQIRUWKH3.&ĮDQG*)$3ODEHOLQJ&K$7LPPXQRUHDFWLYHFHOOFRXQWVGLGQRWVKRZ408 
significant differences between retinal location or implant type for either INL placed (C) or 409 
displaced (D) cholinergic amacrine cells. Error bars represent standard error of the mean. 410 
Figure 4. ChAT labeling in retinal cross-sections from RCS eyes (C-E, implanted from 4 to 8 411 
weeks postnatal) and S334ter-3 eyes (G-I, implanted from 7 to 27 weeks postnatal) with bPVA 412 
devices. Both RCS (B-E) and S334ter-3 sections (F-I), like wild-type (A), show typical 413 
cholinergic amacrine cell morphology with somata in the INL and GCL and processes in a dual-414 
lamination pattern within the IPL. ChAT labeling patterns in implanted areas (C and G) are 415 
identical to those in adjacent (D and H), distal (E and I), Scale bar=50µm. 416 
Figure 5. ChAT-labeled retinal flat mounts from RCS rats implanted from 4 to 8 weeks postnatal 417 
with an mPVA device (C and D) compared to unimplanted control eyes (A and B). En face view 418 
of control INL placed (A) and implanted INL placed (C) ChAT positive amacrine cells shows 419 
similar cholinergic amacrine cell distribution with consistent density. Similarly, labelling patterns 420 
of ChAT positive amacrine cells in the ganglion cell layer were consistent between control (B) 421 
and implanted (D) retinas. Scale bar=50µm.  422 
 423 
Figure 6. GFAP labeling in retinal cross-sections from RCS (B-D) with bPVA and S334ter-3 424 
eyes with mPVA (F-H) and bPVA (K-L) devices. RCS were implanted 4 to 8 weeks postnatally, 425 
while the S334ter-3 animals were implanted at 12 to 32 weeks. Glial reaction is widespread in 426 
all RCS tissue (A-D), but implanted areas (B) do not show increased GFAP labeling in 427 
comparison with adjacent (C), distal (D), and age-matched unimplanted control (A) sections. 428 
Similar to RCS tissue, S334ter-3 sections (E-L) show widespread gliosis due to photoreceptor 429 
19 
degeneration. However, GFAP labeling is not augmented in implanted regions (F and J) relative 430 
to adjacent (G and K), distal (H and L), and age-matched unimplanted control section (E). 431 
S334ter-3 retinas display a characteristic glial seal above the INL, not seen in wild-type retinas 432 
(data not shown), consistent with advanced photoreceptor degeneration. NFL=nerve fiber layer. 433 
Scale bar=50µm. 434 
 435 
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 450 
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